Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Generation of CAR-T Cells with Sleeping Beauty Transposon Gene Transfer.
Methods Mol Biol. 2022;2521:41-66. doi: 10.1007/978-1-0716-2441-8_3.
Methods Mol Biol. 2022.
PMID: 35732992
ROR1-targeting switchable CAR-T cells for cancer therapy.
Peng H, Nerreter T, Mestermann K, Wachter J, Chang J, Hudecek M, Rader C.
Peng H, et al. Among authors: mestermann k.
Oncogene. 2022 Aug;41(34):4104-4114. doi: 10.1038/s41388-022-02416-5. Epub 2022 Jul 20.
Oncogene. 2022.
PMID: 35859167
Free PMC article.
Item in Clipboard
Overcoming key challenges in cancer immunotherapy with engineered T cells.
Arcangeli S, Mestermann K, Weber J, Bonini C, Casucci M, Hudecek M.
Arcangeli S, et al. Among authors: mestermann k.
Curr Opin Oncol. 2020 Sep;32(5):398-407. doi: 10.1097/CCO.0000000000000664.
Curr Opin Oncol. 2020.
PMID: 32796230
Review.
Item in Clipboard
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia.
Jetani H, Navarro-Bailón A, Maucher M, Frenz S, Verbruggen C, Yeguas A, Vidriales MB, González M, Rial Saborido J, Kraus S, Mestermann K, Thomas S, Bonig H, Luu M, Monjezi R, Mougiakakos D, Sauer M, Einsele H, Hudecek M.
Jetani H, et al. Among authors: mestermann k.
Blood. 2021 Nov 11;138(19):1830-1842. doi: 10.1182/blood.2020009192.
Blood. 2021.
PMID: 34289026
Free PMC article.
Item in Clipboard
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells.
Mestermann K, Giavridis T, Weber J, Rydzek J, Frenz S, Nerreter T, Mades A, Sadelain M, Einsele H, Hudecek M.
Mestermann K, et al.
Sci Transl Med. 2019 Jul 3;11(499):eaau5907. doi: 10.1126/scitranslmed.aau5907.
Sci Transl Med. 2019.
PMID: 31270272
Free PMC article.
Item in Clipboard
Correction: ROR1-targeting switchable CAR-T cells for cancer therapy.
Peng H, Nerreter T, Mestermann K, Wachter J, Chang J, Hudecek M, Rader C.
Peng H, et al. Among authors: mestermann k.
Oncogene. 2024 Mar;43(13):992. doi: 10.1038/s41388-024-02965-x.
Oncogene. 2024.
PMID: 38383728
No abstract available.
Item in Clipboard
Cite
Cite